Jeff Sternlicht: Inflammation is The ‘Storm’ Before Atherosclerosis
Jeff Sternlicht, Emergency Physician and Medical Director at Vituity, shared a post on LinkedIn:
“Atherosclerosis is not just a cholesterol problem. It’s also an inflammation problem.
We’ve gotten very good at measuring and treating LDL and Аров.
And that matters.
But there’s another layer of risk that often goes unmeasured.
Inflammation.
hsCRP is a simple blood test that can detect that ‘storm’ long before symptoms, long before an event.
Levels above ~2 mg/L should make us pause and look deeper.
What’s becoming more clear is that even when LDL and ApoB are well controlled, residual inflammatory risk can persist.
This hasn’t always been part of routine screening, but it’s now being recognized more explicitly in newer guidelines.
In my own case, this was a major blind spot.
Lowering ApoB mattered.
But addressing inflammation changed my trajectory.
If we’re not measuring inflammation, we’re not seeing the full picture of risk.
Disclaimer:
Views are my own and not those of my employer or affiliates.
This is for educational purposes only and not medical advice.”
Stay updated with Hemostasis Today.
-
Mar 27, 2026, 16:23Nathan Wong: Lp(a) Testing as a Class I Recommendation in 2026 Guidelines
-
Mar 27, 2026, 16:19Laura Baglow-Micic: Register for the Transfusion Research Network for The SWiFT Trial Results Webinar
-
Mar 27, 2026, 16:18Chris Hannay: Rising Demand for Immunoglobulin Driving Plasma Industry Growth in Canada
-
Mar 27, 2026, 15:33Caitlin Raymond: A Manifesto on Three Foundational Values for a Real Culture of Wellness
-
Mar 27, 2026, 15:30Shankar Biswas: Impact of Coronary Collaterals on Mortality in STEMI
-
Mar 27, 2026, 15:21Joseph Ebubechukwu: The Hidden Impact of Elevated PCV on Patient Wellbeing
-
Mar 27, 2026, 14:53Tooba Rehman: Extending Impella 5.5 Support Beyond 14 Days in Cardiogenic Shock
-
Mar 26, 2026, 17:33Melissa Bouchard: Navigating Prosthetic Valves and Anticoagulation in Pregnancy at ACHD Hive Talks
-
Mar 26, 2026, 17:25Yonah S. Tehrani: Providing Clarity for Anticoagulant Selection in Acute Venous Thromboembolism